[Leish-l] Fwd: PRO/AH/EDR> Leishmaniasis, visceral - East Africa

jeffreyj at usp.br jeffreyj at usp.br
Wed Dec 16 18:56:22 BRST 2015


> From: < promed at promedmail.org >
> Date: 2015-11-23 17:14 GMT-02:00
> Subject: PRO/AH/EDR> Leishmaniasis, visceral - East Africa
> To: promed-post at promedmail.org , promed-edr-post at promedmail.org ,
> promed-ahead-post at promedmail.org

> LEISHMANIASIS, VISCERAL - EAST AFRICA
> *************************************
> A ProMED-mail post
> < http://www.promedmail.org >
> ProMED-mail is a program of the
> International Society for Infectious Diseases
> < http://www.isid.org >

> Date: Fri 20 Nov 2015
> Source: AllAfrica, Daily Nation (Nairobi) report [edited]
> < http://allafrica.com/stories/201511200399.html >

> Visceral leishmaniasis, commonly known as kala-azar, is the most
> deadly parasitic disease after malaria. It affects poor people in
> arid
> and semi-arid regions.

> Eastern Africa is the most affected in Africa, with an estimated 29
> 000 to 56 000 cases every year.

> Like all neglected diseases, kala-azar affects mainly the poorest
> populations that have little or no purchasing power. These population
> groups are usually overlooked and often do not have access to
> life-saving treatments.

> Furthermore, private pharmaceutical companies lack interest in
> producing new drugs for patients suffering from neglected diseases
> since they cannot recoup their investments in drug development.

> Research for new treatments is, therefore, not prioritised, making
> drugs unavailable, inaccessible, and unaffordable.

> In 2003, 4 countries -- Ethiopia, Kenya, Sudan, and Uganda --
> partnered to create the Leishmaniasis East Africa Platform (LEAP),
> the
> main mandate of which was to research new treatment options for
> kala-azar and support their access.

> [Byline: Monique Wasunna, Asrat Hailu]

> --
> Communicated by:
> ProMED-mail from HealthMap Alerts
> < promed at promedmail.org >

> [More information on the Leishmaniasis East Africa Platform (LEAP),
> can be found at
> < http://www.dndi.org/strengthening-capacity/leap-platform.html >.

> Leishmaniasis control is primarily based on control of the sandfly
> vector and the rodent reservoirs. However, human can also act as
> reservoirs and mortality in untreated cases of visceral leishmaniasis
> approach 100 percent.

> Visceral leishmaniasis is also an HIV-associated disease and has a
> more rapid course in HIV infected persons where treatment also is
> difficult even in patients with a high CD4 T cell count. The LEAP
> initiative is therefore an important and very welcome initiative to
> improve treatment of visceral leishmaniasis in East Africa. - Mod.EP]

> [See Also:
> Leishmaniasis, visceral - South Sudan (02):
> http://promedmail.org/post/20151028.3749052
> Leishmaniasis, visceral - South Sudan: (JG):
> http://promedmail.org/post/20150118.3100799
> 2014
> ----
> Leishmaniasis, visceral - South Sudan (03)
> http://promedmail.org/post/20141031.2918104
> Leishmaniasis, visceral - South Sudan (02)
> http://promedmail.org/post/20141006.2836861
> Leishmaniasis, visceral - South Sudan: (JG)
> http://promedmail.org/post/20140909.2760146
> 2012
> ----
> Leishmaniasis, visceral - South Sudan (03): (JG)
> http://promedmail.org/post/20121015.1343672
> Leishmaniasis, visceral - South Sudan (02): (UY)
> http://promedmail.org/post/20120916.1295988
> Leishmaniasis, visceral - South Sudan
> http://promedmail.org/post/20120421.1109078
> 2011
> ----
> Leishmaniasis, visceral - South Sudan (JO, UN)
> http://promedmail.org/post/20111111.3346
> Leishmaniasis, visceral - Sudan: (southern)
> http://promedmail.org/post/20110313.0810
> 2009
> ----
> Leishmaniasis - Sudan: (southern)
> http://promedmail.org/post/20091107.3851
> 2008
> ----
> Leishmaniasis, visceral - Kenya (02): (NE)
> http://promedmail.org/post/20080806.2416
> Leishmaniasis, visceral - Kenya: (NE)
> http://promedmail.org/post/20080613.1871
> 2006
> ----
> Leishmaniasis, visceral - Kenya (Eastern) (02): comment
> http://promedmail.org/post/20060723.2030
> Leishmaniasis, visceral - Kenya (Eastern)
> http://promedmail.org/post/20060721.2007
> 2005
> ----
> Leishmaniasis, visceral - Ethiopia
> http://promedmail.org/post/20050705.1903
> 2000
> ----
> Leishmaniasis, visceral - Kenya (Wajir) (06)
> http://promedmail.org/post/20000828.1439
> Leishmaniasis, visceral - Kenya (Wajir) (05)
> http://promedmail.org/post/20000825.1421
> Leishmaniasis, visceral - Kenya (Wajir) (04)
> http://promedmail.org/post/20000714.1165
> Leishmaniasis, visceral - Kenya (Wajir) (03)
> http://promedmail.org/post/20000705.1113
> Leishmaniasis, visceral - Kenya (Wajir) (02)
> http://promedmail.org/post/20000626.1053
> Leishmaniasis, visceral - Kenya (Wajir)
> http://promedmail.org/post/20000625.1048 ]
> .................................................sb/ep/mj/lm
> *##########################################################*
> ************************************************************
> ProMED-mail makes every effort to verify the reports that
> are posted, but the accuracy and completeness of the
> information, and of any statements or opinions based
> thereon, are not guaranteed. The reader assumes all risks in
> using information posted or archived by ProMED-mail. ISID
> and its associated service providers shall not be held
> responsible for errors or omissions or held liable for any
> damages incurred as a result of use or reliance upon posted
> or archived material.
> ************************************************************
> Donate to ProMED-mail. Details available at:
> < http://www.isid.org/donate/ >
> ************************************************************
> Visit ProMED-mail's web site at < http://www.promedmail.org >.
> Send all items for posting to: promed at promedmail.org (NOT to
> an individual moderator). If you do not give your full name
> name and affiliation, it may not be posted. You may unsub-
> scribe at < http://ww4.isid.org/promedmail/subscribe.php >.
> For assistance from a human being, send mail to:
> < postmaster at promedmail.org >.
> ############################################################
> ############################################################

> List-Unsubscribe: http://ww4.isid.org/promedmail/subscribe.php
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20151216/e9d54e7a/attachment-0001.htm>


More information about the Leish-l mailing list